Health-related quality of life in patients with advanced melanoma treated with ipilimumab: prognostic implications and changes during treatment

BACKGROUND: We have previously reported that the safety and efficacy of ipilimumab in real-world patients with metastatic melanoma were comparable to clinical trials. Few studies have explored health-related quality of life (HRQL) in real-world populations receiving checkpoint inhibitors. This study...

Descripción completa

Detalles Bibliográficos
Autores principales: Aamdal, E., Skovlund, E., Jacobsen, K.D., Straume, O., Kersten, C., Herlofsen, O., Karlsen, J., Hussain, I., Amundsen, A., Dalhaug, A., Nyakas, M., Hagene, K.T., Holmsen, K., Aamdal, S., Kaasa, S., Guren, T.K., Kyte, J.A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588897/
https://www.ncbi.nlm.nih.gov/pubmed/36116420
http://dx.doi.org/10.1016/j.esmoop.2022.100588

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588897/
https://www.ncbi.nlm.nih.gov/pubmed/36116420
http://dx.doi.org/10.1016/j.esmoop.2022.100588

Ejemplares similares